The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children ?s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
Market Analysis and Insights: Global Pediatric Drugs Market
The global Pediatric Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Pediatric Drugs Scope and Segment
The global Pediatric Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
By the end users/application, this report covers the following segments
Hospital
Clinic
Drugstore
Competitive Landscape:
The report provides a list of all the key players in the Pediatric Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Pediatric Drugs key manufacturers in this market include:
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Market Analysis and Insights: Global Pediatric Drugs Market
The global Pediatric Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Pediatric Drugs Scope and Segment
The global Pediatric Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
By the end users/application, this report covers the following segments
Hospital
Clinic
Drugstore
Competitive Landscape:
The report provides a list of all the key players in the Pediatric Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Pediatric Drugs key manufacturers in this market include:
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
1 Pediatric Drugs Market Overview
1.1 Pediatric Drugs Product Overview
1.2 Pediatric Drugs Market Segment by Type
1.2.1 Allergy and Respiratory Drugs
1.2.2 Anti-Infectives
1.2.3 Cancer Therapies
1.2.4 Cardiovascular Drugs
1.2.5 Central Nervous System Drugs
1.2.6 Gastrointestinal Drugs
1.2.7 Hormone Drugs
1.2.8 Urological Drugs
1.3 Global Pediatric Drugs Market Size by Type
1.3.1 Global Pediatric Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Pediatric Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Pediatric Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Pediatric Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Pediatric Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Pediatric Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Pediatric Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Pediatric Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Pediatric Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Type (2016-2021)
2 Global Pediatric Drugs Market Competition by Company
2.1 Global Top Players by Pediatric Drugs Sales (2016-2021)
2.2 Global Top Players by Pediatric Drugs Revenue (2016-2021)
2.3 Global Top Players Pediatric Drugs Price (2016-2021)
2.4 Global Top Manufacturers Pediatric Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Drugs Market Competitive Situation and Trends
2.5.1 Pediatric Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Pediatric Drugs Market
2.8 Key Manufacturers Pediatric Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Drugs Status and Outlook by Region
3.1 Global Pediatric Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Pediatric Drugs Historic Market Size by Region
3.2.1 Global Pediatric Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Pediatric Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Pediatric Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Pediatric Drugs Forecasted Market Size by Region
3.3.1 Global Pediatric Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Pediatric Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Pediatric Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Pediatric Drugs by Application
4.1 Pediatric Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drugstore
4.2 Global Pediatric Drugs Market Size by Application
4.2.1 Global Pediatric Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Pediatric Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Pediatric Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Pediatric Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Pediatric Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Pediatric Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Pediatric Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Pediatric Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Pediatric Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Application (2016-2021)
5 North America Pediatric Drugs by Country
5.1 North America Pediatric Drugs Historic Market Size by Country
5.1.1 North America Pediatric Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Pediatric Drugs Sales in Value by Country (2016-2021)
5.2 North America Pediatric Drugs Forecasted Market Size by Country
5.2.1 North America Pediatric Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Pediatric Drugs Sales in Value by Country (2022-2027)
6 Europe Pediatric Drugs by Country
6.1 Europe Pediatric Drugs Historic Market Size by Country
6.1.1 Europe Pediatric Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Pediatric Drugs Sales in Value by Country (2016-2021)
6.2 Europe Pediatric Drugs Forecasted Market Size by Country
6.2.1 Europe Pediatric Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Pediatric Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Pediatric Drugs by Region
7.1 Asia-Pacific Pediatric Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Pediatric Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2022-2027)
8 Latin America Pediatric Drugs by Country
8.1 Latin America Pediatric Drugs Historic Market Size by Country
8.1.1 Latin America Pediatric Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Pediatric Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Pediatric Drugs Forecasted Market Size by Country
8.2.1 Latin America Pediatric Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Pediatric Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Pediatric Drugs by Country
9.1 Middle East and Africa Pediatric Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Pediatric Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Pediatric Drugs Business
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Corporation Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Abbott Laboratories Pediatric Drugs Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bayer
10.2.1 Bayer Corporation Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Abbott Laboratories Pediatric Drugs Products Offered
10.2.5 Bayer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Corporation Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Boehringer Ingelheim Pediatric Drugs Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Corporation Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bristol-Myers Squibb Pediatric Drugs Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Colgate Oral Pharmaceuticals
10.5.1 Colgate Oral Pharmaceuticals Corporation Information
10.5.2 Colgate Oral Pharmaceuticals Introduction and Business Overview
10.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Products Offered
10.5.5 Colgate Oral Pharmaceuticals Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Corporation Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Eli Lilly Pediatric Drugs Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Forest Laboratories
10.7.1 Forest Laboratories Corporation Information
10.7.2 Forest Laboratories Introduction and Business Overview
10.7.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Forest Laboratories Pediatric Drugs Products Offered
10.7.5 Forest Laboratories Recent Development
10.8 Genentech
10.8.1 Genentech Corporation Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Genentech Pediatric Drugs Products Offered
10.8.5 Genentech Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Corporation Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 GlaxoSmithKline Pediatric Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Pediatric Drugs Product Category, Application and Specification
10.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Johnson & Johnson Recent Development
10.11 MedImmune
10.11.1 MedImmune Corporation Information
10.11.2 MedImmune Introduction and Business Overview
10.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 MedImmune Pediatric Drugs Products Offered
10.11.5 MedImmune Recent Development
10.12 Merck
10.12.1 Merck Corporation Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Merck Pediatric Drugs Products Offered
10.12.5 Merck Recent Development
10.13 Novartis Pharmaceuticals
10.13.1 Novartis Pharmaceuticals Corporation Information
10.13.2 Novartis Pharmaceuticals Introduction and Business Overview
10.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Novartis Pharmaceuticals Pediatric Drugs Products Offered
10.13.5 Novartis Pharmaceuticals Recent Development
10.14 Novo Nordisk
10.14.1 Novo Nordisk Corporation Information
10.14.2 Novo Nordisk Introduction and Business Overview
10.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Novo Nordisk Pediatric Drugs Products Offered
10.14.5 Novo Nordisk Recent Development
10.15 Pfizer
10.15.1 Pfizer Corporation Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Pfizer Pediatric Drugs Products Offered
10.15.5 Pfizer Recent Development
10.16 Pharmacia
10.16.1 Pharmacia Corporation Information
10.16.2 Pharmacia Introduction and Business Overview
10.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Pharmacia Pediatric Drugs Products Offered
10.16.5 Pharmacia Recent Development
10.17 Roche
10.17.1 Roche Corporation Information
10.17.2 Roche Introduction and Business Overview
10.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Roche Pediatric Drugs Products Offered
10.17.5 Roche Recent Development
10.18 Schering-Plough
10.18.1 Schering-Plough Corporation Information
10.18.2 Schering-Plough Introduction and Business Overview
10.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Schering-Plough Pediatric Drugs Products Offered
10.18.5 Schering-Plough Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Drugs Industrial Chain Analysis
11.4 Pediatric Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Drugs Distributors
12.3 Pediatric Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Pediatric Drugs Product Overview
1.2 Pediatric Drugs Market Segment by Type
1.2.1 Allergy and Respiratory Drugs
1.2.2 Anti-Infectives
1.2.3 Cancer Therapies
1.2.4 Cardiovascular Drugs
1.2.5 Central Nervous System Drugs
1.2.6 Gastrointestinal Drugs
1.2.7 Hormone Drugs
1.2.8 Urological Drugs
1.3 Global Pediatric Drugs Market Size by Type
1.3.1 Global Pediatric Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Pediatric Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Pediatric Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Pediatric Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Pediatric Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Pediatric Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Pediatric Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Pediatric Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Pediatric Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Pediatric Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Type (2016-2021)
2 Global Pediatric Drugs Market Competition by Company
2.1 Global Top Players by Pediatric Drugs Sales (2016-2021)
2.2 Global Top Players by Pediatric Drugs Revenue (2016-2021)
2.3 Global Top Players Pediatric Drugs Price (2016-2021)
2.4 Global Top Manufacturers Pediatric Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Drugs Market Competitive Situation and Trends
2.5.1 Pediatric Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Pediatric Drugs Market
2.8 Key Manufacturers Pediatric Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Drugs Status and Outlook by Region
3.1 Global Pediatric Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Pediatric Drugs Historic Market Size by Region
3.2.1 Global Pediatric Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Pediatric Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Pediatric Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Pediatric Drugs Forecasted Market Size by Region
3.3.1 Global Pediatric Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Pediatric Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Pediatric Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Pediatric Drugs by Application
4.1 Pediatric Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drugstore
4.2 Global Pediatric Drugs Market Size by Application
4.2.1 Global Pediatric Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Pediatric Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Pediatric Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Pediatric Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Pediatric Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Pediatric Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Pediatric Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Pediatric Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Pediatric Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Pediatric Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Application (2016-2021)
5 North America Pediatric Drugs by Country
5.1 North America Pediatric Drugs Historic Market Size by Country
5.1.1 North America Pediatric Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Pediatric Drugs Sales in Value by Country (2016-2021)
5.2 North America Pediatric Drugs Forecasted Market Size by Country
5.2.1 North America Pediatric Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Pediatric Drugs Sales in Value by Country (2022-2027)
6 Europe Pediatric Drugs by Country
6.1 Europe Pediatric Drugs Historic Market Size by Country
6.1.1 Europe Pediatric Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Pediatric Drugs Sales in Value by Country (2016-2021)
6.2 Europe Pediatric Drugs Forecasted Market Size by Country
6.2.1 Europe Pediatric Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Pediatric Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Pediatric Drugs by Region
7.1 Asia-Pacific Pediatric Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Pediatric Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2022-2027)
8 Latin America Pediatric Drugs by Country
8.1 Latin America Pediatric Drugs Historic Market Size by Country
8.1.1 Latin America Pediatric Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Pediatric Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Pediatric Drugs Forecasted Market Size by Country
8.2.1 Latin America Pediatric Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Pediatric Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Pediatric Drugs by Country
9.1 Middle East and Africa Pediatric Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Pediatric Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Pediatric Drugs Business
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Corporation Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Abbott Laboratories Pediatric Drugs Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bayer
10.2.1 Bayer Corporation Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Abbott Laboratories Pediatric Drugs Products Offered
10.2.5 Bayer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Corporation Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Boehringer Ingelheim Pediatric Drugs Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Corporation Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bristol-Myers Squibb Pediatric Drugs Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Colgate Oral Pharmaceuticals
10.5.1 Colgate Oral Pharmaceuticals Corporation Information
10.5.2 Colgate Oral Pharmaceuticals Introduction and Business Overview
10.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Products Offered
10.5.5 Colgate Oral Pharmaceuticals Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Corporation Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Eli Lilly Pediatric Drugs Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Forest Laboratories
10.7.1 Forest Laboratories Corporation Information
10.7.2 Forest Laboratories Introduction and Business Overview
10.7.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Forest Laboratories Pediatric Drugs Products Offered
10.7.5 Forest Laboratories Recent Development
10.8 Genentech
10.8.1 Genentech Corporation Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Genentech Pediatric Drugs Products Offered
10.8.5 Genentech Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Corporation Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 GlaxoSmithKline Pediatric Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Pediatric Drugs Product Category, Application and Specification
10.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Johnson & Johnson Recent Development
10.11 MedImmune
10.11.1 MedImmune Corporation Information
10.11.2 MedImmune Introduction and Business Overview
10.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 MedImmune Pediatric Drugs Products Offered
10.11.5 MedImmune Recent Development
10.12 Merck
10.12.1 Merck Corporation Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Merck Pediatric Drugs Products Offered
10.12.5 Merck Recent Development
10.13 Novartis Pharmaceuticals
10.13.1 Novartis Pharmaceuticals Corporation Information
10.13.2 Novartis Pharmaceuticals Introduction and Business Overview
10.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Novartis Pharmaceuticals Pediatric Drugs Products Offered
10.13.5 Novartis Pharmaceuticals Recent Development
10.14 Novo Nordisk
10.14.1 Novo Nordisk Corporation Information
10.14.2 Novo Nordisk Introduction and Business Overview
10.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Novo Nordisk Pediatric Drugs Products Offered
10.14.5 Novo Nordisk Recent Development
10.15 Pfizer
10.15.1 Pfizer Corporation Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Pfizer Pediatric Drugs Products Offered
10.15.5 Pfizer Recent Development
10.16 Pharmacia
10.16.1 Pharmacia Corporation Information
10.16.2 Pharmacia Introduction and Business Overview
10.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Pharmacia Pediatric Drugs Products Offered
10.16.5 Pharmacia Recent Development
10.17 Roche
10.17.1 Roche Corporation Information
10.17.2 Roche Introduction and Business Overview
10.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Roche Pediatric Drugs Products Offered
10.17.5 Roche Recent Development
10.18 Schering-Plough
10.18.1 Schering-Plough Corporation Information
10.18.2 Schering-Plough Introduction and Business Overview
10.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Schering-Plough Pediatric Drugs Products Offered
10.18.5 Schering-Plough Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Drugs Industrial Chain Analysis
11.4 Pediatric Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Drugs Distributors
12.3 Pediatric Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
